Efficacy and safety of the urate-lowering agent febuxostat in chronic heart failure patients with hyperuricemia: results from the LEAF-CHF study
Heart and Vessels · 2025
DOI: 10.1007/s00380-024-02448-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Heart and Vessels, 2025. Verfasst von Takashi Yokota und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. t-yokota@med.hokudai…. Hauptthemen laut MEDLINE: Hyperuricemia, Febuxostat, Heart Failure, Uric Acid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Teijin Pharma Ltd.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. t-yokota@med.hokudai.ac.jp.
- Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Kita-14 Nishi-5, Kita-ku, Sapporo, 060-8648, Japan. t-yokota@med.hokudai.ac.jp.
- Department Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Division of Cardiovascular Medicine, Faculty of Medical Sciences, Research Institute of Angiocardiology, Kyushu University, Fukuoka, Japan.
- Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Förderung
- Teijin Pharma Ltd
Zitieren
APA
Yokota, T., Kinugawa, S., Fukushima, A., Okumura, T., Murohara, T., Tsutsui, H., & LEAF-CHF Investigators (2025). Efficacy and safety of the urate-lowering agent febuxostat in chronic heart failure patients with hyperuricemia: results from the LEAF-CHF study. Heart and Vessels. https://doi.org/10.1007/s00380-024-02448-9
Vancouver
Yokota T, Kinugawa S, Fukushima A, Okumura T, Murohara T, Tsutsui H, et al. Efficacy and safety of the urate-lowering agent febuxostat in chronic heart failure patients with hyperuricemia: results from the LEAF-CHF study. Heart and Vessels. 2025. doi:10.1007/s00380-024-02448-9
BibTeX
@article{Yokota2025,
author = {Yokota, Takashi and Kinugawa, Shintaro and Fukushima, Arata and Okumura, Takahiro and Murohara, Toyoaki and Tsutsui, Hiroyuki and LEAF-CHF Investigators, LEAF-CHF Investigators},
title = {Efficacy and safety of the urate-lowering agent febuxostat in chronic heart failure patients with hyperuricemia: results from the LEAF-CHF study},
journal = {Heart and Vessels},
year = {2025},
doi = {10.1007/s00380-024-02448-9}
}
EUVIMED